{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:34:56Z","timestamp":1792892096885,"version":"4.5.0"},"reference-count":339,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-000707-01"],"award-info":[{"award-number":["MOH-000707-01"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001086-00-00"],"award-info":[{"award-number":["MOH-001086-00-00"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2019100"],"award-info":[{"award-number":["2019100"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118077","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T22:53:26Z","timestamp":1779058406000},"page":"118077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Peripheral biomarkers of neuroinflammation in Alzheimer\u2019s disease and vascular dementia"],"prefix":"10.1016","volume":"250","author":[{"given":"Xiaoxue","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.L.","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuek Ling","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce R.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Ann","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gyu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiruma V.","family":"Arumugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin S.","family":"Dawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7685-1424","authenticated-orcid":false,"given":"Mitchell K.P.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118077_b0005","unstructured":"World Health Organisation, Dementia, 2023, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"10.1016\/j.bcp.2026.118077_b0010","doi-asserted-by":"crossref","unstructured":"F. Neuropathology Group. Medical Research Council Cognitive, S. Aging, Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS), Lancet 357(9251) (2001) 169-75.","DOI":"10.1016\/S0140-6736(00)03589-3"},{"key":"10.1016\/j.bcp.2026.118077_b0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer's disease\u2013lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00401-001-0493-5","article-title":"Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly","volume":"103","author":"Zekry","year":"2002","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/dna.2020.6186","article-title":"The role of autophagy in hypoxia-induced neuroinflammation","volume":"40","author":"Sha","year":"2021","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.201601184","article-title":"Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain","volume":"31","author":"Currais","year":"2017","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-023-01590-1","article-title":"Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment","volume":"11","author":"Rajeev","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0045","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.STR.32.5.1162","article-title":"White matter damage is associated with matrix metalloproteinases in vascular dementia","volume":"32","author":"Rosenberg","year":"2001","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-X","article-title":"Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease","volume":"24","author":"Itagaki","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2026.118077_b0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12974-023-02869-9","article-title":"The mitochondrial protein TSPO in Alzheimer's disease: relation to the severity of AD pathology and the neuroinflammatory environment","volume":"20","author":"Garland","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0065","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11357-022-00556-w","article-title":"Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis","volume":"44","author":"Custodero","year":"2022","journal-title":"Geroscience"},{"key":"10.1016\/j.bcp.2026.118077_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102739","article-title":"Fluid-based biomarkers for neurodegenerative diseases","volume":"108","author":"Cao","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70171","article-title":"Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer's disease","volume":"21","author":"Pola","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0080","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70051","article-title":"The role of glial cell senescence in Alzheimer's disease","volume":"169","author":"Alshaebi","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2026.118077_b0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.dadm.2017.01.001","article-title":"Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease","volume":"7","author":"Zhu","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"10.1016\/j.bcp.2026.118077_b0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2217\/bmm-2017-0433","article-title":"Update on biomarkers for amyloid pathology in Alzheimer's disease","volume":"12","author":"Ashton","year":"2018","journal-title":"Biomark. Med."},{"key":"10.1016\/j.bcp.2026.118077_b0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3389\/fncel.2018.00488","article-title":"Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response","volume":"12","author":"Bachiller","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/WCO.0000000000000911","article-title":"The role of innate immune genes in Alzheimer's disease","volume":"34","author":"Griciuc","year":"2021","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b0115","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2026.118077_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108122","article-title":"Physiology and pharmacology of amyloid precursor protein","volume":"235","author":"Cho","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"33","key":"10.1016\/j.bcp.2026.118077_b0125","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b0130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10571-014-0101-6","article-title":"Microglial A\u03b2 receptors in Alzheimer\u2019s disease","volume":"35","author":"Yu","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bpa.12483","article-title":"Inflammasome activation and innate immunity in Alzheimer's disease","volume":"27","author":"Heneka","year":"2017","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jnr.20767","article-title":"Toll-like receptors in central nervous system glial inflammation and homeostasis","volume":"83","author":"Kielian","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b0150","article-title":"From inflammatory signaling to neuronal damage: Exploring NLR inflammasomes in ageing neurological disorders","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"issue":"Pt 11","key":"10.1016\/j.bcp.2026.118077_b0155","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/brain\/awl249","article-title":"Role of toll-like receptor signalling in Abeta uptake and clearance","volume":"129","author":"Tahara","year":"2006","journal-title":"Brain"},{"issue":"38","key":"10.1016\/j.bcp.2026.118077_b0160","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and toll-like receptors 2 and 4 are required for fibrillar Abeta-stimulated microglial activation","volume":"29","author":"Reed-Geaghan","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13195-023-01186-w","article-title":"Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer's disease in APP\/PS1 mouse","volume":"15","author":"Wang","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imcb.12301","article-title":"The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease","volume":"98","author":"Webers","year":"2020","journal-title":"Immunol. Cell Biol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092587","article-title":"NF-\u03baB pathway and its inhibitors: a promising frontier in the management of Alzheimer's disease","volume":"11","author":"Sivamaruthi","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0185","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.274.10.6421","article-title":"Translation of the Alzheimer amyloid precursor protein mRNA Is Up-regulated by interleukin-1 through 5\u2032-untranslated region sequences*","volume":"274","author":"Rogers","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0190","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"7434","key":"10.1016\/j.bcp.2026.118077_b0195","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"7685","key":"10.1016\/j.bcp.2026.118077_b0200","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","article-title":"Cerebral amyloid angiopathy: a systematic review","volume":"7","author":"Biffi","year":"2011","journal-title":"J. Clin. Neurol."},{"issue":"5\u20136","key":"10.1016\/j.bcp.2026.118077_b0210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: an update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bcp.2026.118077_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105466","article-title":"The role of neuroinflammation in cerebral amyloid angiopathy","volume":"110","author":"van den Brink","year":"2024","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0220","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(04)00825-7","article-title":"Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage","volume":"3","author":"McCarron","year":"2004","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11883-012-0254-z","article-title":"The pathophysiology and clinical presentation of cerebral amyloid angiopathy","volume":"14","author":"Auriel","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.2002.tb00449.x","article-title":"Sporadic and familial cerebral amyloid angiopathies","volume":"12","author":"Revesz","year":"2002","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0235","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0240","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","article-title":"Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly","volume":"116","author":"Cleveland","year":"1977","journal-title":"J. Mol. Biol."},{"issue":"21","key":"10.1016\/j.bcp.2026.118077_b0245","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1073\/pnas.0802036105","article-title":"Complementary dimerization of microtubule-associated tau protein: Implications for microtubule bundling and tau-mediated pathogenesis","volume":"105","author":"Rosenberg","year":"2008","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0250","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0255","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nn.4067","article-title":"Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice","volume":"18","author":"Morris","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0260","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd3207","article-title":"O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer's disease by inhibiting necroptosis","volume":"7","author":"Park","year":"2021","journal-title":"Sci. Adv."},{"issue":"Pt 24","key":"10.1016\/j.bcp.2026.118077_b0265","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1242\/jcs.01558","article-title":"Tau phosphorylation in neuronal cell function and dysfunction","volume":"117","author":"Johnson","year":"2004","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0270","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0275","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2008.03.011","article-title":"Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models","volume":"38","author":"Corsetti","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2026.118077_b0280","first-page":"S123","article-title":"Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration","volume":"33","author":"Wang","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"7434","key":"10.1016\/j.bcp.2026.118077_b0285","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000322228","article-title":"Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation","volume":"8","author":"Bellucci","year":"2011","journal-title":"Neurodegener Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0295","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-016-0221-y","article-title":"Selective suppression of the alpha isoform of p38 MAPK rescues late-stage tau pathology","volume":"8","author":"Maphis","year":"2016","journal-title":"Alzheimers Res. Ther."},{"issue":"7784","key":"10.1016\/j.bcp.2026.118077_b0300","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bcp.2026.118077_b0305","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","article-title":"Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model","volume":"33","author":"Ghosh","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0310","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41467-018-08279-3","article-title":"Neuropathological correlates and genetic architecture of microglial activation in elderly human brain","volume":"10","author":"Felsky","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118077_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101118","article-title":"CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: implications in tauopathies","volume":"22","author":"Castro-Sanchez","year":"2019","journal-title":"Redox Biol."},{"issue":"50","key":"10.1016\/j.bcp.2026.118077_b0320","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1523\/JNEUROSCI.4403-10.2010","article-title":"CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0325","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2353\/ajpath.2010.100265","article-title":"CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models","volume":"177","author":"Lee","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-022-00545-9","article-title":"CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease","volume":"17","author":"Puntambekar","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0335","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1038\/s41467-021-26851-2","article-title":"Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0340","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","article-title":"TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy","volume":"12","author":"Bemiller","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2026.118077_b0345","doi-asserted-by":"crossref","unstructured":"S.H. Lee, W.J. Meilandt, L. Xie, V.D. Gandham, H. Ngu, K.H. Barck, M.G. Rezzonico, J. Imperio, G. Lalehzadeh, M.A. Huntley, K.L. Stark, O. Foreman, R.A.D. Carano, B.A. Friedman, M. Sheng, A. Easton, C.J. Bohlen, D.V. Hansen, Trem2 restrains the enhancement of tau accumulation and neurodegeneration by beta-amyloid pathology, Neuron 109(8) (2021) 1283-1301 e6.","DOI":"10.1016\/j.neuron.2021.02.010"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0350","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0355","first-page":"860","article-title":"Vascular cognitive impairment and dementia","volume":"1862","author":"Gorelick","year":"2016","journal-title":"BBA"},{"issue":"11 Suppl 1","key":"10.1016\/j.bcp.2026.118077_b0360","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1161\/01.STR.0000143318.70292.47","article-title":"Risk factors for vascular dementia and Alzheimer disease","volume":"35","author":"Gorelick","year":"2004","journal-title":"Stroke"},{"issue":"9347","key":"10.1016\/j.bcp.2026.118077_b0365","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/S0140-6736(02)11667-9","article-title":"The dementias","volume":"360","author":"Ritchie","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b0370","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/0963689718795148","article-title":"Cerebral small vessel disease","volume":"27","author":"Li","year":"2018","journal-title":"Cell Transplant."},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0375","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.004","article-title":"Treatment approaches to lacunar stroke","volume":"28","author":"Das","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0380","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","article-title":"Advances in understanding the pathophysiology of lacunar stroke: a review","volume":"75","author":"Regenhardt","year":"2018","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0385","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bcp.2026.118077_b0390","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fnagi.2019.00146","article-title":"Modifiable risk factors for Alzheimer's Disease","volume":"11","author":"Edwards Iii","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"Pt 9","key":"10.1016\/j.bcp.2026.118077_b0395","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"issue":"24","key":"10.1016\/j.bcp.2026.118077_b0400","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0405","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.bcp.2026.118077_b0410","first-page":"2575","article-title":"Cardiovascular comorbidities, inflammation, and cerebral small vessel disease","volume":"117","author":"Evans","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0415","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-021-00506-8","article-title":"The role of inflammasomes in vascular cognitive impairment","volume":"17","author":"Poh","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0425","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70403","article-title":"NLRP3 inflammasome in vascular dementia: regulatory mechanisms, functions, and therapeutic implications: a comprehensive review","volume":"31","author":"Lu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"7575","key":"10.1016\/j.bcp.2026.118077_b0430","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118077_b0435","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fnagi.2014.00159","article-title":"Interactive effects of vascular risk burden and advanced age on cerebral blood flow","volume":"6","author":"Bangen","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0440","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11481-014-9557-x","article-title":"Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease","volume":"9","author":"Hill","year":"2014","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0445","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/physrev.00035.2003","article-title":"Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis","volume":"84","author":"Bazzoni","year":"2004","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b0450","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1172\/JCI60842","article-title":"Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease","volume":"122","author":"Argaw","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0455","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12035-014-8838-y","article-title":"IL-1\u03b2 induces MMP-9-dependent brain astrocytic migration via transactivation of PDGF receptor\/NADPH oxidase 2-derived reactive oxygen species signals","volume":"52","author":"Yang","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0460","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hest.2021.01.002","article-title":"MMP-2\/9-cleaved occludin promotes endothelia cell death in ischemic stroke","volume":"2","author":"Pan","year":"2021","journal-title":"Brain Hemorrhages"},{"key":"10.1016\/j.bcp.2026.118077_b0465","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4504363","article-title":"Destructive effects of pyroptosis on homeostasis of neuron survival associated with the dysfunctional BBB-glymphatic system and amyloid-beta accumulation after cerebral ischemia\/reperfusion in rats","volume":"2021","author":"Lyu","year":"2021","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0470","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cyto.2011.10.016","article-title":"TNF-alpha induced NF\u03baB signaling and p65 (RelA) overexpression repress Cldn5 promoter in mouse brain endothelial cells","volume":"57","author":"Aslam","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2026.118077_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.594672","article-title":"Pathophysiology of blood-brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery","volume":"11","author":"Bernardo-Castro","year":"2020","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0480","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0485","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood-brain barrier: structure, regulation, and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.bcp.2026.118077_b0490","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1088\/0031-9155\/52\/20\/012","article-title":"Regulation of cerebral endothelial cell morphology by extracellular calcium","volume":"52","author":"Wilhelm","year":"2007","journal-title":"Phys. Med. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0495","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","article-title":"Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer's disease model","volume":"101","author":"Merlini","year":"2019","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0500","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0505","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood-brain barrier: structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0510","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2007.09.004","article-title":"NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?","volume":"28","author":"Weggen","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0515","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-180098","article-title":"Role of blood-brain barrier in Alzheimer's disease","volume":"63","author":"Cai","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0520","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10571-015-0256-9","article-title":"Endothelial dysfunction and amyloid-beta-induced neurovascular alterations","volume":"36","author":"Koizumi","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118077_b0525","unstructured":"F.-N.B.W. Group, BEST (Biomarkers, EndpointS, and other Tools) resource. 2016, US FDA: Silver Spring, MD (2016)."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0530","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0535","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-142262","article-title":"Peripheral biomarkers of Alzheimer's disease","volume":"44","author":"Khan","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0540","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"24","key":"10.1016\/j.bcp.2026.118077_b0545","doi-asserted-by":"crossref","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis","volume":"96","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0550","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0555","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/psyg.12403","article-title":"Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"19","author":"Su","year":"2019","journal-title":"Psychogeriatrics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0560","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10072-021-05343-7","article-title":"The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis","volume":"43","author":"Anuradha","year":"2022","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0565","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13195-023-01254-1","article-title":"Blood and CSF chemokines in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"15","author":"Zhou","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0570","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/cdd.2008.172","article-title":"Astroglia in dementia and Alzheimer's disease","volume":"16","author":"Rodriguez","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2026.118077_b0575","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.arr.2014.07.004","article-title":"When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease","volume":"18","author":"Avila-Munoz","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b0580","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal beta-catenin pathway function in an Alzheimer's disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118077_b0585","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","article-title":"Astrogliosis as a therapeutic target for neurodegenerative diseases","volume":"565","author":"Colangelo","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0590","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/glia.20184","article-title":"Spatial and temporal expression of S100B in cells of oligodendrocyte lineage","volume":"51","author":"Hachem","year":"2005","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0595","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neurobiolaging.2008.05.015","article-title":"G. Ageing neuropathology study, astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain","volume":"31","author":"Simpson","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2026.118077_b0600","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-2094-7-78","article-title":"PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation","volume":"7","author":"Roltsch","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2026.118077_b0605","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/929712","article-title":"S100B protein in the nervous system and cardiovascular apparatus in normal and pathological conditions","volume":"2010","author":"Donato","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.bcp.2026.118077_b0610","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3389\/fnins.2019.00640","article-title":"Distribution and relative abundance of S100 proteins in the brain of the APP23 Alzheimer's disease model mice","volume":"13","author":"Hagmeyer","year":"2019","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0615","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/jemt.10303","article-title":"S100B in brain damage and neurodegeneration","volume":"60","author":"Rothermundt","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"11","key":"10.1016\/j.bcp.2026.118077_b0620","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1089\/neu.2012.2579","article-title":"S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury","volume":"30","author":"Goyal","year":"2013","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0625","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0630","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1440-1819.1998.tb02706.x","article-title":"A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases","volume":"52","author":"Muramori","year":"1998","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b0635","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091094","article-title":"Increased YKL-40 but not C-reactive protein levels in patients with Alzheimer's disease","volume":"9","author":"Blanco-Palmero","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0640","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12974-022-02383-4","article-title":"Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer's disease","volume":"19","author":"Munoz-Castro","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0645","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1007\/s12035-020-01950-1","article-title":"Synaptic loss, ER stress and neuro-inflammation emerge late in the lateral temporal cortex and associate with progressive tau pathology in Alzheimer's disease","volume":"57","author":"Buchanan","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0650","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/bpa.12895","article-title":"Distinct changes in all major components of the neurovascular unit across different neuropathological stages of Alzheimer's disease","volume":"30","author":"Kirabali","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bcp.2026.118077_b0655","article-title":"Examining the association between blood-based biomarkers and human post mortem neuropathology in the University of Kentucky Alzheimer's disease research center autopsy cohort","author":"Winder","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0660","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bpa.12812","article-title":"Receptors for pro-resolving mediators are increased in Alzheimer's disease brain","volume":"30","author":"Emre","year":"2020","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0665","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","article-title":"An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum","volume":"17","author":"Van Hulle","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0670","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","article-title":"A. study, Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum","volume":"16","author":"Mila-Aloma","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bcp.2026.118077_b0675","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fnagi.2017.00289","article-title":"Cerebrospinal fluid biomarkers of Alzheimer's disease show different but partially overlapping profile compared to vascular dementia","volume":"9","author":"Llorens","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118077_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134658","article-title":"Alzheimer's disease neuroimaging, cerebrospinal fluid levels of YKL-40 in prodromal Alzheimer's disease","volume":"715","author":"Wang","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0685","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/jnnp-2018-318993","article-title":"Elevated YKL-40 and low sAPPbeta:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD","volume":"90","author":"Alcolea","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"S5","key":"10.1016\/j.bcp.2026.118077_b0690","doi-asserted-by":"crossref","DOI":"10.1002\/alz.067313","article-title":"Comparison between plasma, serum and cerebrospinal fluid glial fibrillary acidic protein in Alzheimer\u2019s disease and dementia with lewy bodies and the effect of age and sex on diagnostic performance","volume":"18","author":"Honey","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bcp.2026.118077_b0695","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.887498","article-title":"Real-world applicability of glial fibrillary acidic protein and neurofilament light chain in Alzheimer's disease","volume":"14","author":"Parvizi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118077_b0700","doi-asserted-by":"crossref","unstructured":"J.L. Dage, A. Eloyan, M. Thangarajah, D.B. Hammers, A.M. Fagan, J.D. Gray, S.E. Schindler, C. Snoddy, K.N.H. Nudelman, K.M. Faber, T. Foroud, P. Aisen, P. Griffin, L.T. Grinberg, L. Iaccarino, K. Kirby, J. Kramer, R. Koeppe, W.A. Kukull, R. La Joie, N.S. Mundada, M.E. Murray, M. Rumbaugh, D.N. Soleimani-Meigooni, A.W. Toga, A. Touroutoglou, P. Vemuri, A. Atri, L.A. Beckett, G.S. Day, N.R. Graff-Radford, R. Duara, L.S. Honig, D.T. Jones, J.C. Masdeu, M.F. Mendez, E. Musiek, C.U. Onyike, M. Riddle, E. Rogalski, S. Salloway, S.J. Sha, R.S. Turner, T.S. Wingo, D.A. Wolk, K.B. Womack, M.C. Carrillo, B.C. Dickerson, G.D. Rabinovici, L.G. Apostolova, L. Consortium, Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study, Alzheimer's & Dementia 19(S9) (2023) S115-S125.","DOI":"10.1002\/alz.13399"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0705","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-023-01168-y","article-title":"Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit","volume":"15","author":"Johnson","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2026.118077_b0710","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer's disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0715","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1567205017666201109095657","article-title":"Cerebrospinal fluid and blood CX3CL1 as a potential biomarker in early diagnosis and prognosis of dementia","volume":"17","author":"Kulczynska-Przybik","year":"2020","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0720","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13195-020-00657-8","article-title":"Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions","volume":"12","author":"Teitsdottir","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bcp.2026.118077_b0725","doi-asserted-by":"crossref","unstructured":"A.L. Benedet, M. Mila-Aloma, A. Vrillon, N.J. Ashton, T.A. Pascoal, F. Lussier, T.K. Karikari, C. Hourregue, E. Cognat, J. Dumurgier, J. Stevenson, N. Rahmouni, V. Pallen, N.M. Poltronetti, G. Salvado, M. Shekari, G. Operto, J.D. Gispert, C. Minguillon, K. Fauria, G. Kollmorgen, I. Suridjan, E.R. Zimmer, H. Zetterberg, J.L. Molinuevo, C. Paquet, P. Rosa-Neto, K. Blennow, M. Suarez-Calvet, A. Translational biomarkers in, A.s. dementia study, s. families, c. BioCogBank paris lariboisiere, differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum, JAMA Neurol 78(12) (2021) 1471-1483.","DOI":"10.1001\/jamaneurol.2021.3671"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0730","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimers Res. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0735","article-title":"Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer's disease, Alzheimer's & Dementia: Diagnosis","volume":"15","author":"Ally","year":"2023","journal-title":"Assessment & Disease Monitoring"},{"issue":"16","key":"10.1016\/j.bcp.2026.118077_b0740","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.scib.2023.07.009","article-title":"Neurodegenerative Initiative, Blood-based biomarkers for Alzheimer's disease: a multicenter-based cross-sectional and longitudinal study in China","volume":"68","author":"Gao","year":"2023","journal-title":"Sci. Bull. (Beijing)"},{"key":"10.1016\/j.bcp.2026.118077_b0745","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1069411","article-title":"Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment","volume":"14","author":"Kivisakk","year":"2023","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b0750","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","article-title":"Plasma glial fibrillary acidic protein in the alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression","volume":"69","author":"Shen","year":"2023","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0755","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0760","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0765","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14577","article-title":"Plasma proteomics for cognitive decline and dementia-A Southeast Asian cohort study","volume":"21","author":"Sim","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0770","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0775","article-title":"Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort","volume":"16","author":"Chong","year":"2024","journal-title":"Alzheimers Dement (Amst)"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0780","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70210","article-title":"Clinical utility of plasma GFAP and NEFL as biomarkers for dementia in the community","volume":"169","author":"Li","year":"2025","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0785","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14502","article-title":"Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease","volume":"21","author":"Chong","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0790","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med."},{"issue":"S2","key":"10.1016\/j.bcp.2026.118077_b0795","doi-asserted-by":"crossref","DOI":"10.1002\/alz.090142","article-title":"Plasma NfL and GFAP for predicting VCID brain changes in the population","volume":"20","author":"Raghavan","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0800","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.18632\/aging.203005","article-title":"S100B gene polymorphisms are associated with the S100B level and Alzheimer's disease risk by altering the miRNA binding capacity","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b0805","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/1567205018666210119145104","article-title":"Association serum S100B protein in Alzheimer's disease: a case control study from South India","volume":"17","author":"Chaudhuri","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bcp.2026.118077_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101494","article-title":"Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer's disease: Evidence of ferroptosis","volume":"32","author":"Ashraf","year":"2020","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0815","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12928","article-title":"Cfas, heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer's and small vessel disease pathologies","volume":"31","author":"Waller","year":"2021","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0820","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-130854","article-title":"Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients","volume":"38","author":"Hu","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b0825","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0830","article-title":"A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease","volume":"12","author":"Edwin","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/j.bcp.2026.118077_b0835","doi-asserted-by":"crossref","unstructured":"Y. Zhao, X. Wu, X. Li, L.L. Jiang, X. Gui, Y. Liu, Y. Sun, B. Zhu, J.C. Pina-Crespo, M. Zhang, N. Zhang, X. Chen, G. Bu, Z. An, T.Y. Huang, H. Xu, TREM2 Is a Receptor for beta-Amyloid that Mediates Microglial Function, Neuron 97(5) (2018) 1023-1031 e7.","DOI":"10.1016\/j.neuron.2018.01.031"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0840","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","article-title":"Glial activation and inflammation along the Alzheimer's disease continuum","volume":"16","author":"Nordengen","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0845","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","article-title":"The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders","volume":"17","author":"Carmona","year":"2018","journal-title":"Lancet Neurol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118077_b0850","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147543","article-title":"Associations between microglia and astrocytic proteins and tau biomarkers across the continuum of alzheimer's disease","volume":"25","author":"Doroszkiewicz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0855","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1038\/s41598-020-72878-8","article-title":"Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification","volume":"10","author":"Knapskog","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0860","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ene.13583","article-title":"Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease","volume":"25","author":"Casati","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bcp.2026.118077_b0865","article-title":"The sTREM2 concentrations in the blood: a marker of neurodegeneration?","volume":"7","author":"Ferri","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0870","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.4049\/jimmunol.2100771","article-title":"Peripheral sTREM2-related inflammatory activity alterations in early-stage Alzheimer's disease","volume":"208","author":"Weber","year":"2022","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0875","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4155\/fmc-2019-0329","article-title":"Radiolabeling of [(11)C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [(11)C]CO2-to-[(11)C]CO chemical conversion","volume":"12","author":"Luzi","year":"2020","journal-title":"Future Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b0880","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/awx120","article-title":"Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease","volume":"140","author":"Parbo","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0885","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1038\/s41467-023-40937-z","article-title":"Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases","volume":"14","author":"Nutma","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b0890","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1177\/0271678X17710182","article-title":"Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans","volume":"37","author":"Owen","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b0895","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/00207454.2019.1702548","article-title":"Association study of serum soluble TREM2 with vascular dementia in Chinese Han population","volume":"130","author":"Wang","year":"2020","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0900","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-022-01118-0","article-title":"D.s. group, Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study","volume":"15","author":"Brosseron","year":"2023","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b0905","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.62347\/MBFD3367","article-title":"Plasma glial fibrillary acidic protein as a biomarker of blood-brain barrier integrity in patients with occult cerebral small vessel disease","volume":"17","author":"Ma","year":"2025","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b0910","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1007\/s11357-024-01498-1","article-title":"Synergistic effects of plasma S100B and MRI measures of cerebrovascular disease on cognition in older adults","volume":"47","author":"Pappas","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.bcp.2026.118077_b0915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2022.06.013","article-title":"Biological correlates of elevated soluble TREM2 in cerebrospinal fluid","volume":"118","author":"Winfree","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2026.118077_b0920","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.03.003","article-title":"Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease","volume":"319","author":"Bekris","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0925","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","article-title":"TREM2 and sTREM2 in Alzheimer's disease: from mechanisms to therapies","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2026.118077_b0930","doi-asserted-by":"crossref","unstructured":"P. Wright, M. Veronese, N. Mazibuko, F.E. Turkheimer, E.A. Rabiner, C.G. Ballard, S.C.R. Williams, A.K. Hari Narayanan, B. Osrah, R. Williams, T.R. Marques, O.D. Howes, F. Roncaroli, M.J. O'Sullivan, Patterns of Mitochondrial TSPO Binding in Cerebral Small Vessel Disease: An in vivo PET Study With Neuropathological Comparison, Frontiers in Neurology Volume 11 - 2020 (2020).","DOI":"10.3389\/fneur.2020.541377"},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0935","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13101","article-title":"Differential perivascular microglial activation in the deep white matter in vascular dementia developed post-stroke","volume":"32","author":"Hase","year":"2022","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0940","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210888","article-title":"Iba-1-\/CD68+ microglia are a prominent feature of age-associated deep subcortical white matter lesions","volume":"14","author":"Waller","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118077_b0945","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.541377","article-title":"Patterns of mitochondrial TSPO binding in cerebral small vessel disease: an in vivo PET study with neuropathological comparison","volume":"11","author":"Wright","year":"2020","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118077_b0950","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1093\/brain\/awab332","article-title":"Plasma soluble TREM2 is associated with white matter lesions independent of amyloid and tau","volume":"144","author":"Tsai","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0955","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.25385","article-title":"Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the hisayama study","volume":"85","author":"Ohara","year":"2019","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b0960","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5414\/NP301368","article-title":"Correlation of serum ferritin levels with neurological function-related indices and cognitive dysfunction in patients with cerebral hemorrhage","volume":"40","author":"Lan","year":"2021","journal-title":"Clin. Neuropathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b0965","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-025-01696-9","article-title":"Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia","volume":"17","author":"Delaby","year":"2025","journal-title":"Alzheimers Res. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b0970","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70717","article-title":"Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic","volume":"21","author":"Eratne","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bcp.2026.118077_b0975","doi-asserted-by":"crossref","unstructured":"P. Erickson, T. Borgh Skillb\u00e4ck, S. Kern, I. Skoog, L. J\u00f6nsson, U. Andreasson, K. Blennow, M. Eriksdotter, H. Zetterberg, Limited Diagnostic Performance of Cerebrospinal Fluid Glial Fibrillary Acidic Protein in Dementia, Dement Geriatr Cogn Disord (2026) 1-9.","DOI":"10.1159\/000550601"},{"key":"10.1016\/j.bcp.2026.118077_b0980","doi-asserted-by":"crossref","unstructured":"M. Gong, J. Jia, Contribution of blood-brain barrier-related blood-borne factors for Alzheimer\u2019s disease vs. vascular dementia diagnosis: A pilot study, Frontiers in Neuroscience Volume 16 - 2022 (2022).","DOI":"10.3389\/fnins.2022.949129"},{"key":"10.1016\/j.bcp.2026.118077_b0985","doi-asserted-by":"crossref","unstructured":"K.N. DuBois, S. Pal, A.C. Maher, J. Heidebrink, C. Persad, B.M. Giordani, B.M. Hampstead, K.M. Bakulski, D.G. Morgan, N.M. Kanaan, Dementia etiology classification using NULISA plasma biomarkers and machine learning, medRxiv (2025).","DOI":"10.64898\/2025.12.02.25340706"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0990","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","article-title":"Plasma proteomic profiles predict future dementia in healthy adults","volume":"4","author":"Guo","year":"2024","journal-title":"Nat. Aging"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b0995","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ana.26822","article-title":"Diagnostic utility of cerebrospinal fluid biomarkers in patients with rapidly progressive dementia","volume":"95","author":"Kuchenbecker","year":"2024","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1000","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease","volume":"2","author":"Patel","year":"2005","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesthesiol. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2353\/ajpath.2007.060708","article-title":"Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging","volume":"170","author":"Csiszar","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s40478-019-0828-x","article-title":"Microglial motility in Alzheimer's disease and after Abeta42 immunotherapy: a human post-mortem study","volume":"7","author":"Franco-Bocanegra","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-160781","article-title":"Increased transforming growth factor beta2 in the neocortex of Alzheimer's disease and dementia with lewy bodies is correlated with disease severity and soluble Abeta42 load","volume":"56","author":"Chong","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b1030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0271678X221146401","article-title":"Chronic cerebral hypoperfusion alters the CypA-EMMPRIN-gelatinase pathway: Implications for vascular dementia","volume":"43","author":"Chai","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41398-021-01349-z","article-title":"Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease","volume":"11","author":"Lyra","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2026.118077_b1040","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.717344","article-title":"Inflammatory biomarkers aid in diagnosis of dementia","volume":"13","author":"Erhardt","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118077_b1045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jneuroim.2018.04.004","article-title":"The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia","volume":"320","author":"Belkhelfa","year":"2018","journal-title":"J. Neuroimmunol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b1050","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neurobiolaging.2015.05.013","article-title":"Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy","volume":"36","author":"Schmitz","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b1055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jpsychires.2006.02.008","article-title":"Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia","volume":"41","author":"Zuliani","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3233\/JAD-231471","article-title":"Search in the periphery for potential inflammatory biomarkers of dementia with lewy bodies and Alzheimer's disease","volume":"99","author":"Costantini","year":"2024","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1065","article-title":"TNF-alpha levels are increased in patients with subjective cognitive impairment and are negatively correlated with beta amyloid-42","volume":"13","author":"Serafini","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bcp.2026.118077_b1070","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.653591","article-title":"Hepcidin Increases cytokines in Alzheimer's disease and down's syndrome dementia: implication of impaired iron homeostasis in neuroinflammation","volume":"13","author":"Raha","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118077_b1075","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1156659","article-title":"Association between IL-6 polymorphisms and atopic dermatitis in chinese han children","volume":"11","author":"Huang","year":"2023","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bcp.2026.118077_b1080","first-page":"1","article-title":"Plasma cytokines profile in patients with Alzheimer's and Parkinson's disease: a comparative study in terms of inflammation","author":"Shateri","year":"2023","journal-title":"Int. J. Neurosci."},{"issue":"4\u20135","key":"10.1016\/j.bcp.2026.118077_b1085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000474940","article-title":"Serum interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in Alzheimer disease patients","volume":"17","author":"D'Anna","year":"2017","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.bcp.2026.118077_b1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136799","article-title":"Tarik Baykal, Decreased levels of cytokines implicate altered immune response in plasma of moderate-stage Alzheimer's disease patients","volume":"786","author":"Koca","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3233\/JAD-180970","article-title":"Identification and preliminary validation of a plasma profile associated with cognitive decline in dementia and at-risk individuals: a retrospective cohort analysis","volume":"67","author":"Iulita","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"16","key":"10.1016\/j.bcp.2026.118077_b1100","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12035-007-0036-8","article-title":"Neuronal chemokines: versatile messengers in central nervous system cell interaction","volume":"36","author":"de Haas","year":"2007","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.nurt.2007.07.004","article-title":"Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?","volume":"4","author":"Savarin-Vuaillat","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/glia.1072","article-title":"Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro","volume":"35","author":"Lue","year":"2001","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b1120","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.152.7.3615","article-title":"Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1","volume":"152","author":"Sozzani","year":"1994","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2008.03.009","article-title":"RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role","volume":"31","author":"Tripathy","year":"2010","journal-title":"Neurobiol. Aging"},{"issue":"17","key":"10.1016\/j.bcp.2026.118077_b1135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713166","article-title":"The relationships between cerebrospinal fluid glial (CXCL12, CX3CL, YKL-40) and synaptic biomarkers (Ng, NPTXR) in early Alzheimer's disease","volume":"24","author":"Kulczynska-Przybik","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1140","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","article-title":"Plasma MCP-1 and Cognitive decline in patients with Alzheimer's disease and mild cognitive impairment: a two-year follow-up study","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1145","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4103\/1673-5374.295340","article-title":"Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer's disease","volume":"16","author":"Vacinova","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1150","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000071001","article-title":"Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease","volume":"16","author":"Sun","year":"2003","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-017-0935-1","article-title":"Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease","volume":"14","author":"Eidson","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2026.118077_b1160","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8818044","article-title":"Correlation between blood and CSF compartment cytokines and chemokines in subjects with cryptococcal meningitis","volume":"2020","author":"Okafor","year":"2020","journal-title":"Mediators Inflamm."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1165","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-023-01976-6","article-title":"The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis","volume":"28","author":"Gigase","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b1170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b1175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/glia.22499","article-title":"Human astrocytes express a novel NLRP2 inflammasome","volume":"61","author":"Minkiewicz","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2026.118077_b1180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b1185","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1190","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","article-title":"Inflammasome activation and IL-1beta and IL-18 processing during infection","volume":"32","author":"van de Veerdonk","year":"2011","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b1195","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","article-title":"Inflammasome signalling in brain function and neurodegenerative disease","volume":"19","author":"Heneka","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b1200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/cr.2015.139","article-title":"Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion","volume":"25","author":"He","year":"2015","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bpa.12478","article-title":"Inflammasomes as therapeutic targets for Alzheimer's disease","volume":"27","author":"White","year":"2017","journal-title":"Brain Pathol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b1210","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1007\/s12035-025-04779-8","article-title":"Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors","volume":"62","author":"Qiao","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"7685","key":"10.1016\/j.bcp.2026.118077_b1215","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-beta in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1220","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","article-title":"Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo","volume":"137","author":"Stancu","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bcp.2026.118077_b1225","doi-asserted-by":"crossref","first-page":"e1382","DOI":"10.1038\/cddis.2014.348","article-title":"Amyloid-beta induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease","volume":"5","author":"Tan","year":"2014","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-025-01210-1","article-title":"GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model","volume":"33","author":"Silva-Llanes","year":"2026","journal-title":"J. Biomed. Sci."},{"issue":"14","key":"10.1016\/j.bcp.2026.118077_b1235","doi-asserted-by":"crossref","DOI":"10.3390\/cells11142223","article-title":"NLRP1 inflammasome activation in the hippocampal formation in Alzheimer's disease: correlation with neuropathological changes and unbiasedly estimated neuronal loss","volume":"11","author":"\u0160pani\u0107","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b1240","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b1245","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jnc.14945","article-title":"Soluble Abeta oligomers and protofibrils induce NLRP3 inflammasome activation in microglia","volume":"155","author":"Luciunaite","year":"2020","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b1250","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer's disease","volume":"74","author":"Tarkowski","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7292","key":"10.1016\/j.bcp.2026.118077_b1255","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nature08890","article-title":"Caspase activation precedes and leads to tangles","volume":"464","author":"de Calignon","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1260","doi-asserted-by":"crossref","first-page":"16551","DOI":"10.1038\/s41598-025-01636-5","article-title":"Thioredoxin-1 inhibits NLRP3-mediated pyroptosis by regulating TXNIP in models of Alzheimer's disease","volume":"15","author":"Jia","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2026.118077_b1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156928","article-title":"Ciliatoside A attenuates neuroinflammation in Alzheimer's disease by activating mitophagy and inhibiting NLRP3 inflammasome activation","volume":"145","author":"Guo","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2026.118077_b1270","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1471005","article-title":"Deficiency of NLRP3 protects cerebral pericytes and attenuates Alzheimer's pathology in tau-transgenic mice","volume":"18","author":"Quan","year":"2024","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1275","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12974-024-03255-9","article-title":"Myeloid gasdermin D drives early-stage T cell immunity and peripheral inflammation in a mouse model of Alzheimer's disease","volume":"21","author":"Rui","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-025-03487-3","article-title":"Liver-specific expression of ANGPTL8 promotes Alzheimer's disease progression through activating microglial pyroptosis","volume":"22","author":"Wei","year":"2025","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1285","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41467-026-68580-4","article-title":"Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina","volume":"17","author":"Gaire","year":"2026","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1290","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-021-02329-2","article-title":"Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease","volume":"18","author":"Rui","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2026.118077_b1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.110945","article-title":"Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease","volume":"136","author":"Scarabino","year":"2020","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2217\/nmt-2019-0003","article-title":"Definition and quantification of six immune- and neuroregulatory serum proteins in healthy and demented elderly","volume":"9","author":"Schipke","year":"2019","journal-title":"Neurodegener Dis Manag"},{"issue":"13","key":"10.1016\/j.bcp.2026.118077_b1305","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134674","article-title":"The inflammasome adaptor protein ASC in mild cognitive impairment and Alzheimer's disease","volume":"21","author":"Scott","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.bcp.2026.118077_b1310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147758","article-title":"The inflammasome adaptor protein ASC in plasma as a biomarker of early cognitive changes","volume":"25","author":"Cyr","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1315","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41467-024-53547-0","article-title":"ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases","volume":"15","author":"Lobanova","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b1320","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/s41380-020-00971-5","article-title":"AIM2 inflammasome mediates hallmark neuropathological alterations and cognitive impairment in a mouse model of vascular dementia","volume":"26","author":"Poh","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299703","article-title":"Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction","volume":"19","author":"Lim","year":"2024","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2026.118077_b1330","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.4103\/NRR.NRR-D-24-01055","article-title":"MCC950 suppresses NLRP3-dependent neuroinflammation and ameliorates cognitive decline in a rat model of cerebral small vessel disease","volume":"21","author":"Zhang","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bcp.2026.118077_b1335","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146779","article-title":"Chronic cerebral hypoperfusion activates AIM2 and NLRP3 inflammasome","volume":"1736","author":"Matsuyama","year":"2020","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1340","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1440-1789.2006.00701.x","article-title":"Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia","volume":"26","author":"Malaguarnera","year":"2006","journal-title":"Neuropathology"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1345","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcag068","article-title":"Elevated serum inflammasome adaptor protein ASC is associated with white matter hyperintensities in vascular cognitive impairment","volume":"8","author":"Chai","year":"2026","journal-title":"Brain Communications"},{"key":"10.1016\/j.bcp.2026.118077_b1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119691","article-title":"Importance of AIM2 as a serum marker for reflecting severity and predicting a poor outcome of human severe traumatic brain injury: A prospective longitudinal cohort study","volume":"559","author":"Chen","year":"2024","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1355","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1038\/s41598-024-61185-1","article-title":"Longitudinal change of serum AIM2 levels after aneurysmal subarachnoid hemorrhage and its prognostic significance: a two-center prospective cohort study","volume":"14","author":"Chen","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1360","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12987-025-00665-6","article-title":"Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia","volume":"22","author":"Akif","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"13","key":"10.1016\/j.bcp.2026.118077_b1365","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.7150\/thno.110389","article-title":"An AIM2 inflammasome biomimetic mineralization inhibitor for vascular dementia therapy","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2026.118077_b1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149548","article-title":"Transcriptomic and network analysis identifies shared pathways across Alzheimer\u2019s disease and vascular dementia","volume":"1854","author":"Zheng","year":"2025","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1375","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2063","article-title":"Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer's disease","volume":"11","author":"Shen","year":"2021","journal-title":"Brain Behav."},{"issue":"8","key":"10.1016\/j.bcp.2026.118077_b1380","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087049","article-title":"Extracellular matrix regulation in physiology and in brain disease","volume":"24","author":"Soles","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118077_b1385","article-title":"Neural stem cell transplantation attenuates cognitive decline and neuroinflammation in a mouse model of Alzheimer's disease with chronic cerebral hypoperfusion","author":"Lu","year":"2025","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2026.118077_b1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115269","article-title":"Stool-derived extracellular vesicles increase inflammasome signaling and regulate the gut-brain axis after stroke in Alzheimer's disease transgenic mice","volume":"390","author":"Kerr","year":"2025","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b1395","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14071354","article-title":"Glial fibrillary acidic protein: a biomarker and drug target for Alzheimer's disease","volume":"14","author":"Ganne","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2026.118077_b1400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijdevneu.2019.06.003","article-title":"Arundic acid administration protects astrocytes, recovers histological damage and memory deficits induced by neonatal hypoxia ischemia in rats","volume":"76","author":"Mari","year":"2019","journal-title":"Int. J. Dev. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1405","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/jpet.106.105171","article-title":"Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice","volume":"318","author":"Mori","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1410","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1039\/D5MD00943J","article-title":"Discovery of a CHI3L1-targeted small molecule modulating neuroinflammation in Alzheimer's disease via DNA-encoded library (DEL) screening","volume":"17","author":"Kaur","year":"2026","journal-title":"RSC Med. Chem."},{"issue":"S6","key":"10.1016\/j.bcp.2026.118077_b1415","article-title":"Characterization of the first TREM2 small molecule agonist, VG-3927, for clinical development in Alzheimer\u2019s disease","volume":"20","author":"Mirescu","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"661","key":"10.1016\/j.bcp.2026.118077_b1420","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq0095","article-title":"A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease","volume":"14","author":"Zhao","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.bcp.2026.118077_b1425","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111549","article-title":"TREM2 agonism with a monoclonal antibody attenuates tau pathology and neurodegeneration","volume":"12","author":"Fassler","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b1430","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1038\/s41591-025-03816-2","article-title":"Rethinking TREM2 as a target for Alzheimer\u2019s disease after the INVOKE-2 trial failure","volume":"31","author":"Colonna","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1435","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41398-023-02630-z","article-title":"Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18\u2009kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease","volume":"13","author":"Pradhan","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2026.118077_b1440","article-title":"Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases","volume":"13\u20132022","author":"Jiao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118077_b1445","doi-asserted-by":"crossref","unstructured":"N. Gonzalez Caldito, Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders, Frontiers in Immunology Volume 14 - 2023 (2023).","DOI":"10.3389\/fimmu.2023.1213448"},{"key":"10.1016\/j.bcp.2026.118077_b1450","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","article-title":"Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice","volume":"102","author":"MacPherson","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b1455","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer's disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b1460","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.040474","article-title":"Protective effects of interleukin-1 inhibition with anakinra in mouse models of ischemic stroke with and without reperfusion","volume":"14","author":"Chaparro-Cabanillas","year":"2025","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1465","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2026.118077_b1470","article-title":"Biomarkers for Alzheimer's disease: context of use, qualification, and roadmap for clinical implementation","volume":"58","author":"Cummings","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b1475","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Proinflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b1480","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1111\/j.1467-789X.2010.00807.x","article-title":"Obesity, weight loss and conditional cardiovascular risk factors","volume":"12","author":"Tzotzas","year":"2011","journal-title":"Obes. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1485","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12933-019-0870-9","article-title":"Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation","volume":"18","author":"Randeria","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1490","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12291-022-01079-z","article-title":"Relationship between cytokines and metabolic syndrome components: role of pancreatic-derived factor, interleukin-37, and tumor necrosis factor-\u03b1 in metabolic syndrome patients","volume":"39","author":"Abdel-Moneim","year":"2024","journal-title":"Indian J. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1495","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10790268.2020.1773029","article-title":"Ibuprofen use is associated with reduced C-reactive protein and interleukin-6 levels in chronic spinal cord injury","volume":"45","author":"Park","year":"2022","journal-title":"J. Spinal Cord Med."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b1500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323749","article-title":"Impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases: a systematic review and meta-analysis","volume":"20","author":"Sabeel","year":"2025","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031772","article-title":"Immunomodulatory activity of the most commonly used antihypertensive drugs-angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers","volume":"23","author":"Bryniarski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118077_b1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117499","article-title":"Serum soluble TREM2 is an independent biomarker associated with coronary heart disease","volume":"548","author":"Liu","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1515","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14302\/issn.2326-0793.jpgr-25-5405","article-title":"Plasma TREM2 levels, alcohol consumption, and liver enzymes in patients with alcohol use disorder: a sex-dependent relationship involving MS4A6A genetic polymorphism","volume":"2","author":"Ho","year":"2025","journal-title":"J Proteom Genom Res"},{"key":"10.1016\/j.bcp.2026.118077_b1520","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112141","article-title":"A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals' models with mild cognitive impairment or dementia","volume":"175","author":"Ayari","year":"2023","journal-title":"Exp. Gerontol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1525","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neulet.2008.03.019","article-title":"Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease","volume":"436","author":"Kim","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2026.118077_b1530","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/00365549509047046","article-title":"Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia","volume":"27","author":"Ortqvist","year":"1995","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.bcp.2026.118077_b1535","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2466-12-6","article-title":"Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ","volume":"12","author":"Zobel","year":"2012","journal-title":"BMC Pulm. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1540","doi-asserted-by":"crossref","DOI":"10.1002\/dneu.22984","article-title":"Neuron-derived extracellular vesicles: emerging biomarkers and functional mediators in Alzheimer's disease, with comparative insights into neurodevelopment and aging","volume":"85","author":"Gonul","year":"2025","journal-title":"Dev. Neurobiol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b1545","doi-asserted-by":"crossref","first-page":"16342","DOI":"10.1007\/s12035-025-05247-z","article-title":"Brain-derived exosomes in neurodevelopmental and neuropsychiatric disorders: molecular insights, therapeutic potential, and translational challenges","volume":"62","author":"Nikanfar","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118077_b1550","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of Alzheimer disease","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118077_b1555","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/acn3.51155","article-title":"Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease","volume":"7","author":"Gu","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1560","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12035-026-05719-w","article-title":"Microglia-derived extracellular vesicles from Alzheimer\u2019s disease patients carry miRNAs driving a neuroinflammatory response","volume":"63","author":"Arbaciauskaite","year":"2026","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118077_b1565","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1007\/s12035-020-02013-1","article-title":"Extracellular vesicles of Alzheimer\u2019s disease patients as a biomarker for disease progression","volume":"57","author":"Aharon","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118077_b1570","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2024.105279","article-title":"Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: a preliminary study","volume":"308","author":"Zhang","year":"2024","journal-title":"J. Proteomics"},{"key":"10.1016\/j.bcp.2026.118077_b1575","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120761","article-title":"FTIR spectroscopy of plasma exosomes reveals distinct lipidomic and proteomic signatures for early Alzheimer's disease detection","volume":"581","author":"Singh","year":"2026","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1580","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13195-022-01133-1","article-title":"Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer\u2019s disease","volume":"14","author":"Cai","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bcp.2026.118077_b1585","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnagi.2018.00343","article-title":"\u201cLiquid biopsy\u201d of white matter hyperintensity in functionally normal elders","volume":"10","author":"Elahi","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118077_b1590","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.881175","article-title":"Circulating exo-miR-154-5p regulates vascular dementia through endothelial progenitor cell-mediated angiogenesis","volume":"16","author":"Han","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"24","key":"10.1016\/j.bcp.2026.118077_b1595","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.21037\/atm-21-6086","article-title":"Exosomal miRNA-223-3p as potential biomarkers in patients with cerebral small vessel disease cognitive impairment","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.bcp.2026.118077_b1600","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2024.137631","article-title":"Identification of differentially expressed exosome proteins in serum as potential biomarkers for cognitive impairments in cerebral small vessel disease","volume":"822","author":"Feng","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1605","first-page":"87","article-title":"The serum exosome derived MicroRNA-135a, -193b, and -384 were potential Alzheimer's disease biomarkers","volume":"31","author":"Yang","year":"2018","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.bcp.2026.118077_b1610","doi-asserted-by":"crossref","unstructured":"J.A. Welsh, D.C.I. Goberdhan, L. O'Driscoll, E.I. Buzas, C. Blenkiron, B. Bussolati, H. Cai, D. Di Vizio, T.A.P. Driedonks, U. Erdbr\u00fcgger, J.M. Falcon-Perez, Q.-L. Fu, A.F. Hill, M. Lenassi, S.K. Lim, M.G. Mahoney, S. Mohanty, A. M\u00f6ller, R. Nieuwland, T. Ochiya, S. Sahoo, A.C. Torrecilhas, L. Zheng, A. Zijlstra, S. Abuelreich, R. Bagabas, P. Bergese, E.M. Bridges, M. Brucale, D. Burger, R.P. Carney, E. Cocucci, R. Crescitelli, E. Hanser, A.L. Harris, N.J. Haughey, A. Hendrix, A.R. Ivanov, T. Jovanovic-Talisman, N.A. Kruh-Garcia, V. Ku'ulei-Lyn Faustino, D. Kyburz, C. L\u00e4sser, K.M. Lennon, J. L\u00f6tvall, A.L. Maddox, E.S. Martens-Uzunova, R.R. Mizenko, L.A. Newman, A. Ridolfi, E. Rohde, T. Rojalin, A. Rowland, A. Saftics, U.S. Sandau, J.A. Saugstad, F. Shekari, S. Swift, D. Ter-Ovanesyan, J.P. Tosar, Z. Useckaite, F. Valle, Z. Varga, E. van der Pol, M.J.C. van Herwijnen, M.H.M. Wauben, A.M. Wehman, S. Williams, A. Zendrini, A.J. Zimmerman, M. Consortium, C. Th\u00e9ry, K.W. Witwer, Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches, J. Extracellular Vesicles 13(2) (2024) e12404.","DOI":"10.1002\/jev2.12404"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1615","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s44400-024-00002-y","article-title":"Alzheimer\u2019s disease and related dementias diagnosis: a biomarkers meta-analysis of general and CNS extracellular vesicles","volume":"1","author":"Taha","year":"2025","journal-title":"npj Dementia"},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1620","doi-asserted-by":"crossref","first-page":"29260","DOI":"10.3402\/jev.v4.29260","article-title":"Handling and storage of human body fluids for analysis of extracellular vesicles","volume":"4","author":"Yuana","year":"2015","journal-title":"J. Extracellular Vesicles"},{"issue":"12","key":"10.1016\/j.bcp.2026.118077_b1625","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70931","article-title":"Enhancing diagnostic precision in Alzheimer's disease: impact of comorbidities on blood biomarkers for clinical integration","volume":"21","author":"Daniilidou","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1630","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytox.2020.100027","article-title":"Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: platform performance in post-traumatic stress disorder and Parkinson's disease","volume":"2","author":"Lasseter","year":"2020","journal-title":"Cytokine X"},{"key":"10.1016\/j.bcp.2026.118077_b1635","doi-asserted-by":"crossref","unstructured":"J.B. Libby, K.D. Deters, N. Ertekin-Taner, M.M. Carrasquillo, M. Allen, P. De Jager, V. Menon, B. Zhang, V. Haroutunian, A.I. Levey, N.T. Seyfried, R. Kaddurah-Daouk, S. Finkbeiner, D. Wang, A.K. Greenwood, A. Vander Linden, L. Heath, W.L. Poehlman, L. Dumitrescu, V.A. Petyuk, D.A. Bennett, J.A. Schneider, L.L. Barnes, T.J. Hohman, Multi-omic expression of the VEGF family relates to Alzheimer's disease across diverse populations, Alzheimer's & Dementia : J. Alzheimer's Association 22(1) (2026) e71100.","DOI":"10.1002\/alz.71100"},{"key":"10.1016\/j.bcp.2026.118077_b1640","doi-asserted-by":"crossref","unstructured":"M.M. Reid, S. Menon, H. Liu, H. Zhou, Z. Hu, S. Frerich, B. Ding, S. Oveisgharan, Z. Zhang, S. Nelson, A. Apolonio, D.A. Bennett, M. Dichgans, K.S. Pollard, M.R. Corces, A.C. Yang, Human brain vascular multi-omics elucidates disease-risk associations, Neuron 113(19) (2025) 3143-3161 e5.","DOI":"10.1016\/j.neuron.2025.07.001"},{"key":"10.1016\/j.bcp.2026.118077_b1645","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1630783","article-title":"Multi-omics reveals the protective mechanisms of Gastrodia elata ethyl acetate extract in vascular dementia","volume":"17","author":"Tao","year":"2026","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1650","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13760-025-02804-0","article-title":"Serum ferritin levels linked to cognitive decline and biomarker profiles in dementia with lewy bodies","volume":"125","author":"Ren","year":"2025","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.bcp.2026.118077_b1655","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1660","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bpa.12763","article-title":"Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains","volume":"30","author":"Gui","year":"2020","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1665","doi-asserted-by":"crossref","first-page":"11","DOI":"10.30773\/pi.2020.0205","article-title":"The association of blood-based inflammatory factors IL-1beta, TGF-beta and CRP with cognitive function in Alzheimer's disease and mild cognitive impairment","volume":"18","author":"Park","year":"2021","journal-title":"Psychiatry Investig"},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1670","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2007.06.006","article-title":"Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients","volume":"30","author":"Ojala","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bcp.2026.118077_b1675","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115094","article-title":"Advances in peripheral blood biomarkers of patients with Alzheimer's disease: Moving closer to personalized therapies","volume":"165","author":"Ferretti","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2026.118077_b1680","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","article-title":"Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons","volume":"145","author":"Moonen","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118077_b1685","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13142","article-title":"Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease","volume":"33","author":"Vontell","year":"2023","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1690","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1038\/s41467-025-56756-3","article-title":"Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort","volume":"16","author":"Santos","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2026.118077_b1695","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12974-019-1531-3","article-title":"Plasma YKL-40 in the spectrum of neurodegenerative dementia","volume":"16","author":"Villar-Piqu\u00e9","year":"2019","journal-title":"J. Neuroinflammation"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:37:07Z","timestamp":1792888627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":339,"alternative-id":["S0006295226004120"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118077","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral biomarkers of neuroinflammation in Alzheimer\u2019s disease and vascular dementia","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118077"}}